GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (STU:8G8) » Definitions » YoY EPS Growth

CS Medica AS (STU:8G8) YoY EPS Growth : 80.00% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CS Medica AS YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. CS Medica AS's YoY EPS Growth for the quarter that ended in Sep. 2024 was 80.00%.

CS Medica AS's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was €-0.01.


CS Medica AS YoY EPS Growth Historical Data

The historical data trend for CS Medica AS's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS YoY EPS Growth Chart

CS Medica AS Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
YoY EPS Growth
Get a 7-Day Free Trial - 1,700.00 -881.25 -26.40 51.90

CS Medica AS Quarterly Data
Sep19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,900.00 -5.26 48.65 20.93 80.00

CS Medica AS YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

CS Medica AS's YoY EPS Growth for the fiscal year that ended in Sep. 2024 is calculated as:

YoY EPS Growth (A: Sep. 2024 )
=(Earnings per Share (Diluted) (A: Sep. 2024 )-Earnings per Share (Diluted) (A: Sep. 2023 ))/ | Earnings per Share (Diluted) (A: Sep. 2023 ) |
=(-0.076--0.158)/ | -0.158 |
=51.90 %

CS Medica AS's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(-0.008--0.04)/ | -0.04 |
=80.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CS Medica AS YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of CS Medica AS's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


CS Medica AS Business Description

Traded in Other Exchanges
N/A
Address
Indiakaj 10, Copenhagen, DNK, 2100
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines